doi: 10.3389/fphar.2026.1789257 Received 16 January 2026 Revised 20 April 2026 Accepted 22 April 2026 Published 20 May 2026 Volume 17 - 2026 Edited by Cyril Ronco, Universit Cte d'Azur, France Reviewed by Finbarr P
In some cases, individuals might experience weight loss that is too rapid or exceeds their goals
Slower aging
Ideal candidates for GHK-Cu before and after transformations, based on published research and user reports, include: People in their 30s and early 40s are noticing the first signs of aging People with photoaged or sun-damaged skin People with sensitive, reactive, or rosacea-prone skin People recovering from microneedling, lasers, or peels People dealing with hyperpigmentation, melasma, or acne marks People with early-to-moderate hair thinning People in their 50s and beyond focused on maintenance First-time peptide users looking for a gentle starting point Severe deep wrinkles, advanced sagging, significant volume loss, and fully dead hair follicles wont respond significantly
The small-molecular drugs from various pharmacological classes and different phytoceuticals repurposed against PCOS are discussed along with their anti-PCOS activity mechanisms
Individuals with one or two copies of the genetic variation and low activity of the MTHFR enzyme may present with elevated homocysteine levels, which have been associated with inflammation, heart disease, pregnancy complications, and even miscarriages
